These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 17233471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Koshino M, Kudou D, Okoshi Y, Obara N, Simizu S, Mukai HY, Suzukawa K, Hasegawa Y, Kojima H, Nagasawa T, Chiba S.
    Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L, Delforge M, Dierickx D.
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [Abstract] [Full Text] [Related]

  • 5. [Refractory thrombotic thrombocytopenic purpura successfully treated with a combination of rituximab and vincristine].
    Kaneko H, Matsumoto M, Okamoto K, Chyonabayashi K, Hishizawa M, Watanabe M, Fujimura Y, Tsudo M.
    Rinsho Ketsueki; 2007 Feb; 48(2):144-7. PubMed ID: 17370643
    [Abstract] [Full Text] [Related]

  • 6. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 7. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ.
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
    Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.
    Blood; 2005 Sep 15; 106(6):1932-7. PubMed ID: 15933059
    [Abstract] [Full Text] [Related]

  • 10. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.
    Int J Hematol; 2005 Jun 15; 81(5):433-6. PubMed ID: 16158827
    [Abstract] [Full Text] [Related]

  • 11. Thrombotic thrombocytopenic purpura in pediatric patients.
    Steele M, Chen HH, Steele J, Chan AK, Lau KK.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov 15; 14(11):803-10. PubMed ID: 23146723
    [Abstract] [Full Text] [Related]

  • 12. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
    Caramazza D, Quintini G, Abbene I, Malato A, Saccullo G, Lo Coco L, Di Trapani R, Palazzolo R, Barone R, Mazzola G, Rizzo S, Ragonese P, Aridon P, Abbadessa V, Siragusa S.
    Transfusion; 2010 Dec 15; 50(12):2753-60. PubMed ID: 20576013
    [Abstract] [Full Text] [Related]

  • 13. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
    van Balen T, Schreuder MF, de Jong H, van de Kar NC.
    Eur J Haematol; 2014 Jan 15; 92(1):80-2. PubMed ID: 24118335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.
    Thromb Haemost; 2009 Feb 15; 101(2):233-8. PubMed ID: 19190804
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
    Rüfer A, Brodmann D, Gregor M, Kremer Hovinga JA, Lämmle B, Wuillemin WA.
    Swiss Med Wkly; 2007 Sep 22; 137(37-38):518-24. PubMed ID: 17990141
    [Abstract] [Full Text] [Related]

  • 19. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder MA.
    Ann Intern Med; 2003 Jan 21; 138(2):105-8. PubMed ID: 12529092
    [Abstract] [Full Text] [Related]

  • 20. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Sadler JE.
    Blood; 2008 Jul 01; 112(1):11-8. PubMed ID: 18574040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.